71 related articles for article (PubMed ID: 11726210)
1. Identification of structural domains affecting transactivation potential of Nm23.
Cho SJ; Lee NS; Jung YS; Lee H; Lee KJ; Kim E; Chae SK
Biochem Biophys Res Commun; 2001 Dec; 289(3):738-43. PubMed ID: 11726210
[TBL] [Abstract][Full Text] [Related]
2. Point mutations affecting the oligomeric structure of Nm23-H1 abrogates its inhibitory activity on colonization and invasion of prostate cancer cells.
Kim YI; Park S; Jeoung DI; Lee H
Biochem Biophys Res Commun; 2003 Jul; 307(2):281-9. PubMed ID: 12859952
[TBL] [Abstract][Full Text] [Related]
3. Double mutant P96S/S120G of Nm23-H1 abrogates its NDPK activity and motility-suppressive ability.
Zhou Q; Yang X; Zhu D; Ma L; Zhu W; Sun Z; Yang Q
Biochem Biophys Res Commun; 2007 May; 356(2):348-53. PubMed ID: 17335772
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis.
Negroni A; Venturelli D; Tanno B; Amendola R; Ransac S; Cesi V; Calabretta B; Raschellà G
Cell Death Differ; 2000 Sep; 7(9):843-50. PubMed ID: 11042679
[TBL] [Abstract][Full Text] [Related]
5. Nm23-M2/NDP kinase B induces endogenous c-myc and nm23-M1/NDP kinase A overexpression in BAF3 cells. Both NDP kinases protect the cells from oxidative stress-induced death.
Arnaud-Dabernat S; Masse K; Smani M; Peuchant E; Landry M; Bourbon PM; Le Floch R; Daniel JY; Larou M
Exp Cell Res; 2004 Dec; 301(2):293-304. PubMed ID: 15530864
[TBL] [Abstract][Full Text] [Related]
6. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
[TBL] [Abstract][Full Text] [Related]
7. Transactivation potential of the C-terminus of human Nm23-H1.
Chae SK; Lee NS; Lee KJ; Kim E
FEBS Lett; 1998 Feb; 423(2):235-8. PubMed ID: 9512364
[TBL] [Abstract][Full Text] [Related]
8. Structure-based mutational and functional analysis identify human NM23-H2 as a multifunctional enzyme.
Postel EH; Abramczyk BA; Gursky SK; Xu Y
Biochemistry; 2002 May; 41(20):6330-7. PubMed ID: 12009894
[TBL] [Abstract][Full Text] [Related]
9. The human nm23-H4 gene product is a mitochondrial nucleoside diphosphate kinase.
Milon L; Meyer P; Chiadmi M; Munier A; Johansson M; Karlsson A; Lascu I; Capeau J; Janin J; Lacombe ML
J Biol Chem; 2000 May; 275(19):14264-72. PubMed ID: 10799505
[TBL] [Abstract][Full Text] [Related]
10. nm23: unraveling its biological function in cell differentiation.
Lombardi D; Lacombe ML; Paggi MG
J Cell Physiol; 2000 Feb; 182(2):144-9. PubMed ID: 10623877
[TBL] [Abstract][Full Text] [Related]
11. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway.
Hartsough MT; Morrison DK; Salerno M; Palmieri D; Ouatas T; Mair M; Patrick J; Steeg PS
J Biol Chem; 2002 Aug; 277(35):32389-99. PubMed ID: 12105213
[TBL] [Abstract][Full Text] [Related]
12. Specific biochemical inactivation of oncogenic Ras proteins by nucleoside diphosphate kinase.
Fischbach MA; Settleman J
Cancer Res; 2003 Jul; 63(14):4089-94. PubMed ID: 12874011
[TBL] [Abstract][Full Text] [Related]
13. Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro.
Freije JM; Blay P; MacDonald NJ; Manrow RE; Steeg PS
J Biol Chem; 1997 Feb; 272(9):5525-32. PubMed ID: 9038158
[TBL] [Abstract][Full Text] [Related]
14. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
Godfried MB; Veenstra M; v Sluis P; Boon K; v Asperen R; Hermus MC; v Schaik BD; Voûte TP; Schwab M; Versteeg R; Caron HN
Oncogene; 2002 Mar; 21(13):2097-101. PubMed ID: 11960382
[TBL] [Abstract][Full Text] [Related]
15. Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metastatic potential.
Liu F; Zhang Y; Zhang XY; Chen HL
J Cancer Res Clin Oncol; 2002 Apr; 128(4):189-96. PubMed ID: 11935309
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of NM23-H2/NDP kinase identifies the structural domains critical to recognition of a c-myc regulatory element.
Postel EH; Weiss VH; Beneken J; Kirtane A
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6892-7. PubMed ID: 8692914
[TBL] [Abstract][Full Text] [Related]
17. [Expression of nm23-H1 gene in oral squamous cell carcinoma and its relation to tumor metastasis].
Zhang T; Lai Q; Du D; Zhao Y; Chai J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Feb; 21(1):19-24. PubMed ID: 12569635
[TBL] [Abstract][Full Text] [Related]
18. Histidine to aspartate phosphotransferase activity of nm23 proteins: phosphorylation of aldolase C on Asp-319.
Wagner PD; Vu ND
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):623-30. PubMed ID: 10698688
[TBL] [Abstract][Full Text] [Related]
19. [The prognostic relation of nm23-H1/NDPK-A with leukemia and lymphoma].
Li HY; Liu JS; Wang YF
Sheng Li Ke Xue Jin Zhan; 2003 Jan; 34(1):74-7. PubMed ID: 12778818
[No Abstract] [Full Text] [Related]
20. Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity.
Wagner PD; Steeg PS; Vu ND
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9000-5. PubMed ID: 9256424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
